Home / CDx/IVD Products / NGS-Based Assays / Detection of Blood Cancer Gene Mutation
Detection of Blood Cancer Gene Mutation

HEMECDx is a high-throughput gene detection product for leukemia and lymphoma patients independently developed by MEDx Translational Medicine (Suzhou) Co., Ltd. (MEDx). MEDx provides physicians and patients with a number of products used to conduct a comprehensive analysis of the genome (DNA) and transcriptome (RNA) in order to help clinicians make right diagnosis and prognosis stratification, treatment, and recurrence monitoring.

Indications

MDS、MPN、Acute and chronic leukemia, various lymphomas

Test content

505 gene mutations(DNA)

Clinical significance

It is used for the cancer diagnosis, prognostic stratification, targeted therapy, chemical sensitivity analysis, HLA typing, immune checkpoint inhibitor marker detection, tumor neoantigens, etc.

If you have any of the following needs, feel free to contact us or email us at inquiry@MEDxTMC.net . We will reply within 24 hours.


1. Customized or bulk orders of IVD/CDx products.

2. Get a quote for IVD/CDx products

3. Become our distributor

4. Get customized pharmaceutical service solutions

5.Learn more about our technology and R&D


Show of MEDx by CCTV